St John's wort versus paroxetine for depression.
作者信息
Jurcic Jane, Pereira Jennifer A, Kavanaugh Devon
机构信息
Agro Health Associates Inc in Burlington, Ontario, Canada.
出版信息
Can Fam Physician. 2007 Sep;53(9):1511-3.
Abstract
摘要
相似文献
1
St John's wort versus paroxetine for depression.
Can Fam Physician. 2007 Sep;53(9):1511-3.
2
Evaluating the safety of St. John's Wort in human pregnancy.
Reprod Toxicol. 2009 Jul;28(1):96-9. doi: 10.1016/j.reprotox.2009.02.003. Epub 2009 Feb 24.
3
Effects of Hypericum perforatum (St. John's wort) on hot flashes and quality of life in perimenopausal women: a randomized pilot trial.
Menopause. 2009 Mar-Apr;16(2):307-14. doi: 10.1097/gme.0b013e31818572a0.
4
Protective effect of St. John's wort (Hypericum perforatum) extract on 72-hour sleep deprivation-induced anxiety-like behavior and oxidative damage in mice.
Planta Med. 2007 Oct;73(13):1358-64. doi: 10.1055/s-2007-990234. Epub 2007 Oct 4.
5
Long-term effects of St. John's wort (Hypericum perforatum) treatment: a 1-year safety study in mild to moderate depression.
Phytomedicine. 2009 Apr;16(4):277-83. doi: 10.1016/j.phymed.2008.12.023. Epub 2009 Mar 18.
6
Effect of St John's wort on the disposition of fexofenadine in the isolated perfused rat liver.
J Pharm Pharmacol. 2009 Aug;61(8):1037-42. doi: 10.1211/jpp/61.08.0007.
7
St John's wort: a prestigious 'weed'.
Aust J Holist Nurs. 2004 Oct;11(2):30-4.
8
Skin tolerance of a new bath oil containing St. John's wort extract.
Skin Pharmacol Physiol. 2008;21(6):306-11. doi: 10.1159/000148223. Epub 2008 Jul 31.
9
Herbal supplements and therapeutic drug monitoring: focus on digoxin immunoassays and interactions with St. John's wort.
Ther Drug Monit. 2008 Apr;30(2):212-7. doi: 10.1097/FTD.0b013e31816b918f.
10
Review: St John's wort superior to placebo and similar to antidepressants for major depression but with fewer side effects.
Evid Based Ment Health. 2009 Aug;12(3):78. doi: 10.1136/ebmh.12.3.78.
引用本文的文献
1
Effectiveness of stop smoking interventions among adults: protocol for an overview of systematic reviews and an updated systematic review.
Syst Rev. 2019 Jan 19;8(1):28. doi: 10.1186/s13643-018-0928-x.
2
Evaluation of Pharmaceutical Products of St. John's Wort Efficacy Added on Tricyclic Antidepressants in treating Major Depressive Disorder: A Double Blind Randomized Control Trial.
Jundishapur J Nat Pharm Prod. 2012 Summer;7(3):106-10. Epub 2012 Aug 25.
本文引用的文献
1
St John's wort for depression: meta-analysis of randomised controlled trials.
Br J Psychiatry. 2005 Feb;186:99-107. doi: 10.1192/bjp.186.2.99.
2
Complementary and alternative medicine use among adults: United States, 2002.
Adv Data. 2004 May 27(343):1-19.
3
Analysis of the hypericin and pseudohypericin content of commercially available St John's Wort preparations.
Can J Clin Pharmacol. 2003 Fall;10(3):114-8.
4
Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis.
BMJ. 2003 May 10;326(7397):1014. doi: 10.1136/bmj.326.7397.1014.
5
Natural health product use in Canada.
Can J Public Health. 2002 Nov-Dec;93(6):426-30. doi: 10.1007/BF03405030.
6
Clinical guidelines for the treatment of depressive disorders.
Can J Psychiatry. 2001 Jun;46 Suppl 1:5S-90S.
7
Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial.
JAMA. 2002 Apr 10;287(14):1807-14. doi: 10.1001/jama.287.14.1807.
8
Systematic review and guide to selection of selective serotonin reuptake inhibitors.
Drugs. 1999 Apr;57(4):507-33. doi: 10.2165/00003495-199957040-00005.
9
The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment.
Arch Gen Psychiatry. 1998 Jul;55(7):580-92. doi: 10.1001/archpsyc.55.7.580.
Zotero 插件